Literature DB >> 11406454

The cancer cachexia syndrome.

K C Fearon1, M D Barber, A G Moses.   

Abstract

The provision of additional calories and protein alone has not been shown to be efficacious in patients with cancer cachexia. Although primary research continues to unravel the complex metabolic derangements and diverse mediator pathways underlying cancer cachexia, the future lies in drugs and neutracenticals that may modulate this altered metabolism and enable conventional nutritional support to effectively replenish vital lean tissue.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11406454

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  8 in total

1.  Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.

Authors:  K C H Fearon; M F Von Meyenfeldt; A G W Moses; R Van Geenen; A Roy; D J Gouma; A Giacosa; A Van Gossum; J Bauer; M D Barber; N K Aaronson; A C Voss; M J Tisdale
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

2.  Nutritional screening tools in daily clinical practice: the focus on cancer.

Authors:  Michèle Leuenberger; Silvia Kurmann; Zeno Stanga
Journal:  Support Care Cancer       Date:  2010-01-20       Impact factor: 3.603

Review 3.  Connexin- and pannexin-based channels in normal skeletal muscles and their possible role in muscle atrophy.

Authors:  Luis A Cea; Manuel A Riquelme; Bruno A Cisterna; Carlos Puebla; José L Vega; Maximiliano Rovegno; Juan C Sáez
Journal:  J Membr Biol       Date:  2012-08-01       Impact factor: 1.843

4.  Evaluation of Weight Change During Carboplatin Therapy in Dogs With Appendicular Osteosarcoma.

Authors:  A L Story; S E Boston; J J Kilkenny; A Singh; J P Woods; W T N Culp; K A Skorupski; X Lu
Journal:  J Vet Intern Med       Date:  2017-05-15       Impact factor: 3.333

Review 5.  Nutrition in Cancer Patients.

Authors:  Paula Ravasco
Journal:  J Clin Med       Date:  2019-08-14       Impact factor: 4.241

6.  Randomised controlled trial testing the feasibility of an exercise and nutrition intervention for patients with ovarian cancer during and after first-line chemotherapy (BENITA-study).

Authors:  Tabea Maurer; Matthias Hans Belau; Julia von Grundherr; Zoe Schlemmer; Stefan Patra; Heiko Becher; Karl-Heinz Schulz; Birgit-Christiane Zyriax; Barbara Schmalfeldt; Jenny Chang-Claude
Journal:  BMJ Open       Date:  2022-02-23       Impact factor: 2.692

7.  Chemotherapy-Related Toxicity, Nutritional Status and Quality of Life in Precachectic Oncologic Patients with, or without, High Protein Nutritional Support. A Prospective, Randomized Study.

Authors:  Monika Ziętarska; Joanna Krawczyk-Lipiec; Leszek Kraj; Renata Zaucha; Sylwia Małgorzewicz
Journal:  Nutrients       Date:  2017-10-11       Impact factor: 5.717

8.  The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.

Authors:  H R Scott; D C McMillan; L M Forrest; D J F Brown; C S McArdle; R Milroy
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.